Streetbeat News

Regulatory

HYMTF

KIMTF

TSLA

Hyundai Motor Co and Kia Corp are intensifying their electric vehicle (EV) efforts to compete with Tesla Inc, according to Ross Gerber, CEO of Gerber Kawasaki Wealth and Investment Management. Despite being cheaper, Gerber believes these EVs are not as good as Tesla's offerings. The South Korean government is supporting Hyundai and Kia with new EV policies, while Tesla continues to face challenges, including concerns about a potential production slump.

Portfolio Pulse from Benzinga Neuro

April 02, 2024 | 1:45 am

TCNNF

VRNOF

The Florida Supreme Court's decision to allow a cannabis legalization amendment on the November 2024 ballot has been met with enthusiasm from the cannabis community, including executives from Trulieve Cannabis Corp (TCNNF) and Verano Holdings Corp (VRNOF). Both companies have expressed their support for the initiative, which could significantly impact the cannabis market in Florida, the nation's largest medical cannabis market.

Portfolio Pulse from Maureen Meehan

April 01, 2024 | 11:21 pm

MSFT

OpenAI, backed by a significant investment from Microsoft Corp (NASDAQ:MSFT), unveiled its new product, 'Voice Engine,' a voice cloning tool. This development marks Microsoft's aggressive expansion into the AI space. Voice Engine, which has been in development for two years, allows users to clone voices from a 15-second sample. Despite potential risks associated with deepfake technology, OpenAI emphasizes responsible deployment. The tool is initially available to a select group of developers.

Portfolio Pulse from Chris Katje

April 01, 2024 | 10:45 pm

CVS

HUM

UNH

Shares of UnitedHealth Group Inc (UNH), Humana Inc (HUM), and CVS Health Corp (CVS) fell in after-hours trading following the CMS's announcement of finalized payment updates for Medicare Advantage and Part D programs for 2025. The updates include a 3.7% average increase in payments to MA plans and improvements to Part D drug benefits, capping annual out-of-pocket costs at $2,000.

Portfolio Pulse from Adam Eckert

April 01, 2024 | 9:00 pm

EVRG

Evergy has submitted its Triennial Integrated Resource Plan to the Missouri Public Service Commission, detailing its strategy to address customer electricity needs for the next 20 years. The plan emphasizes the addition of renewable and dispatchable generation sources to cater to rising demand from economic development and new capacity requirements by the Southwest Power Pool.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 8:57 pm

LIFW

PLTR

Palantir Technologies Inc. has reported a 6.5% stake in MSP Recovery, Inc. as of March 22, 2024, according to a 13G filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 8:49 pm

TCNNF

The Florida Supreme Court approved Amendment 3 for the November 2024 ballot, which proposes the legalization of recreational marijuana for adults over 21. Trulieve Cannabis (OTCQX:TCNNF), having contributed significantly to the advocacy group Smart & Safe, stands to benefit if the amendment passes. Florida's Attorney General opposed the measure, citing concerns over federal legality. The amendment allows for possession, purchase, and use of marijuana, with Medical Marijuana Treatment Centers able to sell to adults for personal use starting May 2025 if approved.

Portfolio Pulse from Maureen Meehan

April 01, 2024 | 8:37 pm

XWELL

XWELL Inc. announced its intention to file Form 12b-25 with the SEC to extend the filing deadline of its Form 10-K. This move indicates a delay in the submission of the company's annual financial report.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 8:35 pm

CNC

CVS

ELV

HUM

MOH

UNH

Shares of healthcare providers CNC, CVS, ELV, HUM, MOH, and UNH are trading lower following the CMS's finalization of payment updates for the 2025 Medicare Advantage and Medicare Part D programs.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 8:35 pm

LFWD

Lifeward CEO Larry Jasinski issued an open letter to shareholders updating on the progress with CMS to finalize a Medicare payment rate for the ReWalk Exoskeleton. The payment rate was deferred in the HCPCS final determination, but CMS has indicated it can update the April 2024 DMEPOS fee schedule to include exoskeletons once the rate is established. Lifeward is actively working with CMS and has submitted 35 Medicare claims, with one already paid and more in review. An additional 60-75 claims are planned for submission by end of 2024.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 8:34 pm